Downloads: 27 | Views: 132 | Weekly Hits: ⮙7 | Monthly Hits: ⮙7

Research Paper | Ayurveda | India | Volume 13 Issue 12, December 2024 | Popularity: 7.7 / 10

Rate This Article!       View 2 Comments

Clinical Effectiveness of Vasa Kantakari Kwatha in the Management of Tamak Shwasa (Bronchial Asthma) in Children

Dr. Darshana Jain, Dr. Minaj Dosani, Dr. Harish Kumar Singhal

Abstract: Respiratory diseases, particularly asthma, present a significant global health burden. Tamaka Shwasa, an Ayurvedic concept, is closely correlated with bronchial asthma, characterized by an imbalance of Vata and Kapha, resulting in obstruction of the respiratory passages. This study aimed to evaluate the clinical effectiveness of Vasa Kantakari Kwatha in managing Tamaka Shwasa in children. A total of 10 children aged 5 - 12 years with mild persistent bronchial asthma participated in a 30 - day trial. The drug, composed of Vasa (Adhatoda vasica) and Kantakari (Solanum virginianum), was administered in calculated doses based on the child's age. Efficacy was assessed using subjective parameters (cough, wheezing, dyspnoea, and others) and objective parameters (CBC, FEV1, ESR). Results showed highly significant improvements in symptoms such as cough (55.55%), wheezing (50%), dyspnea (53.57%), and sleep disturbance (68%). Objective parameters, including WBC count, eosinophils, Hb, ESR, FEV1, and PEFR, also showed significant positive changes. The average overall effectiveness of the treatment was 60.09% which suggested that Vasa Kantakari Kwatha was found an effective formulation in managing Tamaka Shwasa having no adverse effects.

Keywords: Adhatoda Vasica, Ayurveda, Asthma, Bronchitis, Breathlessness, Cough, Dyspnea, Kantakari, Solanum virginianum, Vasa

Edition: Volume 13 Issue 12, December 2024

Pages: 199 - 202

DOI: https://www.doi.org/10.21275/MR241202180226

Make Sure to Disable the Pop-Up Blocker of Web Browser

Click to Cite this Article

Similar Articles